Search clinical trials for: Hyperphosphatemia

Total 163 results

Novartis

Completed

Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients (SBR759)

Chronic Kidney Disease | Hyperphosphatemia

Belgium, Italy
Novartis Pharmaceuticals

Completed

Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis (SBR759)

Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy

Germany, United Kingdom, Italy, Belgium, Sweden, Canada, United States, Australia, Finland, France, Norway, Puerto Rico, Switzerland
Translational Research Center for Medical Innovation...
Showa University School of Medicine

Completed

Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study (LANDMARK)

Hemodialysis | Hyperphosphatemia

Japan
RWTH Aachen University

Terminated

Velphoro and Impact on the Oral Cavity and Gut Microbiome (MicrobiomEisen)

Hyperphosphatemia

Germany
University of Illinois at Chicago
Shire

Completed

Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients

Hyperphosphatemia | Kidney Disease

United States
Ardelyx

Completed

Dose Finding Study to Treat High Phosphate Levels in the Blood.

Hyperphosphatemia

United States, Poland, United Kingdom, Slovakia
Ardelyx

Completed

An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)

Hyperphosphatemia

United States
Bayer

Completed

Fosrenol Post-marketing Surveillance for Hemodialysis in Japan (FOSRENOL-HD)

Hyperphosphatemia

Japan
Astellas Pharma Inc

Completed

Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis

Chronic Renal Failure

Japan
University College Cork
Cork University Hospital; Irish Nutrition & Dietetic Institute

Completed

Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices (DIP HD)

Hyperphosphatemia | Dietary Modification | Renal Dialysis

Ireland
Panion & BF Biotech Inc.

Completed

Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis

Kidney Failure, Chronic | Hyperphosphatemia | Phosphorus Metabolism Disorders | End-stage Renal Disease

Taiwan
Panion & BF Biotech Inc.

Completed

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease

End Stage Renal Disease | ESRD | Hyperphosphatemia

Taiwan
University of Illinois at Chicago
Shire

Completed

Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum Carbonate

Hyperphosphatemia in Chronic Kidney Disease

United States
Vifor Fresenius Medical Care Renal Pharma

Completed

Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) (VERIFIE)

Hyperphosphatemia

Spain, Netherlands, Germany, Italy, France, Greece, United Kingdom
Vifor Fresenius Medical Care Renal Pharma

Terminated

A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia

Hyperphosphatemia

United States, Poland, Germany, Lithuania, France, Romania, Russian Federation
Daiichi Sankyo, Inc.

Completed

DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis

Hyperphosphatemia

United States
Astellas Pharma Inc

Completed

Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan

Chronic Kidney Disease | Hyperphosphatemia Undergoing Hemodialysis

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis | Hyperphosphatemia

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis Patients With Hyperphosphatemia

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis | Hyperphosphatemia

Japan
Wan-Chuan Tsai

Completed

Low-Phosphate Diet and Fibroblast Growth Factor-23 Level

Hyperphosphatemia | Dietary Intervention | Chronic Kidney Disease Requiring Chronic Dialysis | Elevated Fibroblast Growth Factor-23

Taiwan
Chugai Pharmaceutical

Completed

A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

Hyperphosphatemia

United States
Veterans Medical Research Foundation
San Diego Veterans Healthcare System

Unknown

Phosphate Microvascular Study

End Stage Renal Disease | Hyperphosphatemia
Kissei Pharmaceutical Co., Ltd.

Completed

PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia

Chronic Kidney Disease Requiring Hemodialysis

Japan
Denver Nephrologists, P.C.
Keryx Biopharmaceuticals

Completed

Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D (05D)

Renal Insufficiency | Chronic Kidney Disease | Iron Deficiency Anemia | Hyperphosphatemia

United States
NYU Langone Health

Completed

Behavioral Management of Phosphorus in Hemodialysis Patients

Hyperphosphatemia | Cardiovascular Disease (CKD)

United States
Huashan Hospital

Completed

Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients

Hyperphosphatemia | End-stage Renal Disease

China
Bayer

Completed

Fosrenol Post-marketing Surveillance in Japan

Hyperphosphatemia | Kidney Disease

Japan
Bayer

Completed

Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan (FOSRENOL-CAPD)

Hyperphosphatemia

Japan
Phosphate Therapeutics
Clinipace Worldwide

Completed

Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease

Hyperphosphataemia
Romanian Society of Nephrology

Withdrawn

Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate

Hyperphosphatemia | Haemodialyzed Patients

Romania
University Hospital, Montpellier

Completed

Serum Phosphatemia Predictive Marker for AKI Diagnosis After Cardiac Surgery (PhosphoIRA)

Cardiac Surgery With Cardiopulmonary Bypass | Complete Serum Phosphorus Measure | Complete Serum Creatinine Measure

France
Federico II University

Unknown

Egg White for Phosphorus Control in Haemodialysis Patients (UAUDIPE)

Renal Insufficiency, Chronic | Hyperphosphatemia | Dialysis

Italy
Brigham and Women's Hospital

Terminated

The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan

Inflammation | Cardiovascular Disease | Atherosclerosis | Hyperphosphatemia | Dialysis

United States
Assiut University

Unknown

Hyperphosphatemia in Children With Chronic Kidney Disease

Hyperphosphatemia
Assiut University

Unknown

The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis

Hyperphosphatemia
Mitsubishi Tanabe Pharma Corporation

Completed

Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects

Chronic Kidney Disease | Hyperphosphatemia

United Kingdom
Lundquist Institute for Biomedical Innovation at...

Completed

Fosrenol and Phosphorus Balance - Lanthanum Carbonate

End-stage Renal Disease | Chronic Kidney Failure | Disorders Associated With Peritoneal Dialysis

United States
Keryx Biopharmaceuticals
Collaborative Study Group (CSG)

Completed

A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)

Hyperphosphatemia | End-stage Renal Disease

United States
University of Sao Paulo

Completed

Educational Programme Impact on Serum Phosphate Control (EPIC)

Renal Insufficiency, Chronic

Brazil
Astellas Pharma Inc

Completed

Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients

Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis

Japan
Novartis Pharmaceuticals

Completed

Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis (SBR759)

Chronic Kidney Disease

Taiwan, Japan
Haukeland University Hospital

Unknown

Hypophosphatemic Rickets in Norway

Hyperphosphatemia | Rickets | Hypophosphatemia, Familial

Norway
Jiujiang No.1 People's Hospital

Unknown

Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia (NAHPH)

Hyperphosphatemia

China
Genzyme, a Sanofi Company

Completed

An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease

Chronic Kidney Disease | Hyperphosphatemia

United States, France, Germany, Lithuania, Poland
Keryx Biopharmaceuticals

Completed

A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis

Renal Failure | End Stage Renal Disease | ESRD | Kidney Failure | Hyperphosphatemia

United States, Puerto Rico
Astellas Pharma Inc

Completed

Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

Japan
Ajou University School of Medicine

Completed

Efficacy of Dietary Education and Education on Phosphate Binder Use in Hemodialysis Patients

Hyperphosphatemia | End-stage Renal Disease
Bayer

Completed

Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients

Hyperphosphatemia

Japan
Amgen

Completed

Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia

End Stage Renal Disease | Chronic Kidney Disease | Kidney Disease | Hyperphosphatemic

Search clinical trials for: Hyperphosphatemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations